Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Lidocaine-Dexmedetomidine Combination Therapy in Reducing Post-Operative Pain, Inflammatory Response, and Oxidative Stress in Patients Undergoing Bariatric Surgery

NCT07073846 is registered in ClinicalTrials.gov with Instituto Mexicano del Seguro Social as lead sponsor.

NCT NCT07073846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07073846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Lidocaine-Dexmedetomidine Combination Therapy in Reducing Post-Operative Pain, Inflammatory Response, and Oxidative Stress in Patients Undergoing Bariatric Surgery
Lead sponsor
Instituto Mexicano del Seguro Social
Phase
Phase 4
Overall status
Recruiting
Start date
October 6, 2025
Completion date
July 1, 2027
Enrollment
104 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

morbid obesity requiring bariatric surgery, postoperative adjuvant treatment, postoperative analgesia, postoperative inflammatory markers, postoperative inflammatory response, postoperative pain, postoperative pain management